Escitalopram in the treatment of panic disorder: a randomized, double-blind, placebo-controlled trial.
about
Effect of pharmacotherapy for anxiety disorders on quality of life: a meta-analysisCanadian clinical practice guidelines for the management of anxiety, posttraumatic stress and obsessive-compulsive disordersExercise as Treatment for Anxiety: Systematic Review and Analysis.Time to response in panic disorder in a naturalistic setting: combination therapy with alprazolam orally disintegrating tablets and serotonin reuptake inhibitors compared to serotonin reuptake inhibitors alone.The selective serotonin reuptake inhibitor, escitalopram, enhances inhibition of prepotent responding and spatial reversal learningIs the efficacy of antidepressants in panic disorder mediated by adverse events? A mediational analysis.Long-term Escitalopram Treatment in Korean Patients with Panic Disorder: A Prospective, Naturalistic, Open-label, Multicenter Trial.Effect of age, weight, and CYP2C19 genotype on escitalopram exposure.Pharmacotherapy of panic disorder.INFLUENCE OF STUDY DESIGN ON TREATMENT RESPONSE IN ANXIETY DISORDER CLINICAL TRIALSThe therapeutic potential of escitalopram in the treatment of panic disorder.The effect of reporting methods for dosing times on the estimation of pharmacokinetic parameters of escitalopram.Antianxiety medications for the treatment of complex agoraphobia: pharmacological interventions for a behavioral conditionCorrespondence (reply): In reply
P2860
Q26851668-9E435F33-98AE-487F-B563-5965090EE1C6Q27009995-4EC775E5-30A5-4B25-8B9A-AEFD04AFDCA4Q27693304-21535E3F-2842-4C6F-9265-2B123092143FQ34156583-604AAF05-04D2-4197-A78E-27658C9DD36CQ35937022-CC0D09EC-7C67-4A82-B209-0C97E5BF424FQ36390869-5B901337-1CED-4E8F-8382-B8AB3E064EF8Q36600821-1B0167F7-2FC1-4C4E-91C6-5792480851E6Q36606190-07235D0B-56CF-434F-B2CA-264257627E5CQ36876452-BFA1C79E-FBB2-4BED-9BC2-AB822F9719BEQ37041164-FD9C2DD9-6A0F-4AE3-A17B-C38C10798DB8Q37129822-C9264ADD-789D-4B4B-B7DD-E80BE6BAA1CDQ37207545-FB815841-C3A1-4591-A4E0-AE348DA7A779Q37957090-3CE7CAEA-3370-4D68-8B50-EF611AFCE637Q56827259-A0B83C0B-29CC-4000-8893-992D0425BC85
P2860
Escitalopram in the treatment of panic disorder: a randomized, double-blind, placebo-controlled trial.
description
2003 nî lūn-bûn
@nan
2003 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
name
Escitalopram in the treatment ...... ind, placebo-controlled trial.
@ast
Escitalopram in the treatment ...... ind, placebo-controlled trial.
@en
Escitalopram in the treatment ...... ind, placebo-controlled trial.
@nl
type
label
Escitalopram in the treatment ...... ind, placebo-controlled trial.
@ast
Escitalopram in the treatment ...... ind, placebo-controlled trial.
@en
Escitalopram in the treatment ...... ind, placebo-controlled trial.
@nl
prefLabel
Escitalopram in the treatment ...... ind, placebo-controlled trial.
@ast
Escitalopram in the treatment ...... ind, placebo-controlled trial.
@en
Escitalopram in the treatment ...... ind, placebo-controlled trial.
@nl
P2093
P356
P1476
Escitalopram in the treatment ...... lind, placebo-controlled trial
@en
P2093
Ivan Gergel
Stephen M Stahl
P304
P356
10.4088/JCP.V64N1107
P577
2003-11-01T00:00:00Z